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Abstract.  Many adhesion receptors have high three- 
dimensional dissociation constants (Kd) for counter- 
receptors compared to the Kds of receptors for soluble 
extracellular ligands such as cytokines and hormones. 
Interaction of the T lymphocyte adhesion receptor 
CD2 with its counter-receptor, LFA-3, has a high solu- 
tion-phase/Ca (16 txM at 37°C), yet the CD2/LFA-3 in- 
teraction serves as an effective adhesion mechanism. 
We have studied the interaction of CD2 with LFA-3 in 
the contact area between Jurkat T lymphoblasts and 
planar phospholipid bilayers containing purified, fluo- 
rescently labeled LFA-3. Redistribution and lateral 
mobility of LFA-3 were measured in contact areas as 
functions of the initial LFA-3 surface density and of 
time after contact of the cells with the bilayers. LFA-3 
accumulated at sites of contact with a half-time of ~15 
min, consistent with the previously determined kinetics 
of adhesion strengthening. The two-dimensional Ka for 
the CD2/LFA-3 interaction was 21 molecules/txm  2, 
which is lower than the surface densities of CD2 on T 
cells and LFA-3 on most target or stimulator cells. 
Thus, formation of CD2/LFA-3 complexes should be 
highly favored in physiological interactions. Compari- 
son of the two-dimensional (membrane-bound) and 
three-dimensional (solution-phase) Kas suggest that 
cell-ceU contact favors CD2/LFA-3 interaction to a 
greater extent than that predicted by the three-dimen- 
sional Ka and the intermembrane distance at the site of 
contact. LFA-3 molecules in the contact site were capa- 
ble of lateral diffusion in the plane of the phospholipid 
bilayer and did not appear to be irreversibly trapped in 
the contact area, consistent with a rapid off-rate. These 
data provide insights into the function of low affinity  in- 
teractions in adhesion. 
M 
ULTICELLULAR organisms  use  cell  contact  and 
adhesion for both structural integrity and short 
range  communication. In the immune system, 
adhesion of T cells to antigen presenting cells (APCs)  1 is 
mediated by antigen receptors  and  adhesion receptors. 
The T  cell antigen  receptor and the accessory molecules 
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CD4 and CD8  (cluster  of differention antigens 4 and 8) 
bind directly to antigenic peptide: major histocompatibil- 
ity complex (MHC) protein adducts (15, 24, 31). Parallel 
interactions  involving CD2 with lymphocyte function-asso- 
ciated antigen 3 (LFA-3) and LFA-1 with ICAMs 1, 2, and 
3 are required for stable  cell-cell adhesion (14, 18, 40). 
CD2 and LFA-3 are members of the immunoglobulin su- 
perfamily (IgSF),  each possessing  two  fg-like  domains, 
that bind to each other through an interaction involving 
their NH2-terminal  Ig-like domains (1, 20, 32, 39). If the 
mode of interaction between CD2 and LFA-3 is similar to 
that employed by other adhesion molecules of the IgSF, 
then the CD2/LFA-3 interaction may serve as a prototype 
for adhesive interactions involved in neural cell adhesion, 
cell migration in development and tumor cell metastasis. 
The CD2/LFA-3 interaction was the first heterophilic 
adhesion mechanism to be fully reconstituted (17, 37, 41). 
It was also the first heterophilic mechanism for which the 
solution-phase  interaction was  rigorously analyzed.  The 
dissociation  constant (Kd) and off-rate for the interaction 
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×  10 -5 M and greater than 4 s -1, respectively (45). It has 
been suggested that the high Ka and fast off-rate of the 
CD2/LFA-3  interaction  allows  for cell--cell  dissociation, 
which is essential for the migration of long-lived T  lym- 
phocytes (44). 
Before the description of heterophilic adhesion mecha- 
nisms  such as that involving CD2  and LFA-3, the three 
part interaction among cellular Fc receptors, hapten-spe- 
cific antibody, and hapten-coated surfaces  or liposomes 
provided an important model for molecular studies of ad- 
hesion. A classic study by McCloskey and Poo (26) showed 
that the interaction of a cell bearing fluorescently labeled 
anti-DNP antibody-IgeFc receptor complexes with a lipo- 
some incorporating DNP-labeled phospholipids efficiently 
drove  accumulation  of antibody-Fc receptor  complexes 
into the area of contact between the cell and the liposome. 
This "trapping" effect correlated with adhesion strength- 
ening.  Receptor accumulation  did not  require  an  active 
contribution from the cell, suggesting that it was driven by 
the  extracellular binding interaction (Kd  =  10  -s M)  be- 
tween antibody and DNP. Although this study did demon- 
strate  the  importance  of adhesion  molecule  trapping  in 
contact areas as a general mechanism, it did not determine 
an upper limit for the K d of an interaction that could be 
mediated by this trapping or syn-capping effect. This is an 
important  question,  since  the  CD2/LFA-3  interaction 
functions in adhesion with a solution-phase Kd of 16 p~M. 
Other  studies  showing  redistribution  of adhesion  mole- 
cules to contact areas have not excluded (or have specifi- 
cally invoked) interactions with the cytoskeleton as a con- 
tributing  or  necessary  process  in  adhesion  receptor 
accumulation (10, 11, 21, 22, 28, 30, 48). Therefore, such 
studies do not directly address the role of the Kd of adhe- 
sion receptor interactions in receptor redistribution. 
We have previously shown that a glycosylphosphatidyl- 
inositol anchored isoform of LFA-3 (GPI-LFA-3) is more 
potent than a transmembrane isoform in mediating adhe- 
sion of CD2 ÷ T lymphoblasts to glass-supported planar bi- 
layers reconstituted with LFA-3 (9). This difference in po- 
tency is  related  to  the  observation that  transmembrane 
proteins are laterally immobile (9, 27), whereas phospho- 
lipids (9, 27) and GPI-anchored proteins (9) are laterally 
mobile,  in  glass-supported  planar  bilayers.  One  likely 
mechanism for the effect of lateral diffusion on adhesion 
involves an increase in the rate of productive collisions be- 
tween laterally mobile LFA-3 and CD2. A  second likely 
mechanism involves trapping of laterally mobile LFA-3 in 
the contact area, which increases the effective LFA-3 den- 
sity. In the present study we have labeled purified GPI- 
LFA-3 with FITC, incorporated FITC-LFA-3 into glass- 
supported planar  bilayers, and  characterized changes  in 
the surface distribution and diffusion coefficient of LFA-3 
induced  by interaction  with  CD2 ÷ T  lymphoblasts.  We 
find that LFA-3 accumulates in contact areas with T lym- 
phoblasts.  Equilibrium  binding  analysis  shows  that  the 
two-dimensional Ka for the CD2/LFA-3 interaction is low 
relative to the normal surface densities of CD2 and LFA-3 
in  biological  membranes,  suggesting  that  binding  ap- 
proaches saturation in biological contact areas. Compari- 
son between two- and three-dimensional Kas for the CD2/ 
LFA-3 interaction suggests that CD2 and LFA-3 are un- 
der topological constraints such as those described by Bell 
et al. (4) as a "confinement region", or a thin subregion of 
volume within the contact area in which adhesion mole- 
cule binding sites are localized. Finally, we detect lateral 
diffusion of "bound" LFA-3 in the contact area, consistent 
with a rapid off-rate for the CD2/LFA-3 binding interaction. 
Materials and Methods 
Monoclonal Antibodies and Cell Lines 
The monoclonal antibodies TS2/9  (anti-LFA-3) and TS2/18  (anti-CD2) 
were originally  described in Sanchez-Madrid et al. (34). The Jurkat T lym- 
phoma cell line was maintained in RPMI 1640 containing 10%  fetal bo- 
vine serum, 5 mM glutamine and 50 p.g/ml gentamicin. Jurkat cells in log 
phase of growth (6-9 ×  105 cells/ml) were used for all experiments. 
Purification and Modification of  LFA-3 
GPI-LFA-3 was affinity-purified  from human erythrocytes, as previously 
described (17). To avoid modification of the CD2 binding surface on criti- 
cal lysines, LFA-3 was bound to TS2/9-coupled Sepharose CL-4B  before 
conjugation with FITC. Purified LFA-3 was added in a sufficient amount 
to saturate 1 ml of TS2/9 Sepharose CL-4B  (2 mg/ml) in neutralized elu- 
tion buffer, and the mixture was rotated at 4°C for 4--16 h. The Sepharose 
was washed extensively at 4°C in 0.1 M NaHCO3/Na2CO3,  pH 9.0, 0.05% 
Triton X-100, and excess buffer was removed. FITC was dissolved  in di- 
methylformamide to a concentration of 80 mM, and the solution was di- 
luted 1:9 in 1 ml of 0.1 M NaHCO3/Na2CO3,  pH 9.0, 0.05%  Triton X-100 
and added immediately to the LFA-3 TS2/9 Sepharose mixture. After 2 h 
of end over end rotation at room temperature the slurry was centrifuged, 
the supernatant was removed, a fresh preparation of 8 mM FITC in 0.1 M 
NaHCO3/Na2CO3,  pH 9.0, 0.05%  Triton X-100 was added, and the room 
temperature incubation was repeated. The slurry was transferred to a c01- 
umn and washed with 50 volumes of 25 mM Tris, pH 8.6, 0.15 M NaCI, 1% 
octyl-13-D-glucopyranoside  (OG). FITC-modified LFA-3 (FITC-LFA-3) 
was eluted with 50 mM glycine,  pH 3.0, 0.15 M NaC1, 1%  OG and col- 
lected  in tubes containing 1 M Tris, pH 8.6, 1% OG. 
Preparation of  Liposomes and Planar Bilayers 
Unilamellar liposomes were prepared by OG dialysis  (7,29).  Egg phos- 
phatidylcholine  (PC)  (Avanti Polar  Lipids,  Inc.,  Pelham, AL) was dis- 
solved at 0.4 mM in 25 mM Tris, pH 8.0, 0.15 M NaCI, 2% OG, and then 
mixed with an equal volume of 25 mM Tris, pH 8.0, 0.15 M NaCI, 2% OG 
containing different amounts of LFA-3 or FITC-LFA-3. Liposome sus- 
pensions were formed by dialysis and stored at 4°C under argon to mini- 
mize lipid oxidation. 
Planar  bilayers  containing  purified  LFA-3  or  FITC-LFA-3  were 
formed as previously described (17), with the following modifications.  In 
some experiments, bilayers were formed from a mixture of liposomes con- 
taining FITC-LFA-3 and  purified  LFA-1  (16).  A  diamond pencil  was 
used to place a shallow scratch in the center of clean coverslips to permit 
identification  of the plane of the bilayer.  In a 2-1 tank of 25 mM Hepes, pH 
7.4, 147 mM NaC1, 5 mM glucose, 1% bovine serum albumin (HBS), the 
planar bilayer bearing coverslips were transferred to glass slides  that had 
been coated with 10-ram rings of vacuum grease (Dow-Corning, Corning, 
NY). A Jurkat cell suspension was pipetted within the grease ring just as 
the coverslip was slowly lowered and pressed into the grease to trap a 
small number of cells. The incubation was initiated when the system was 
inverted coverslip down. In some cases,  CD2 molecules on Jurkat cells 
were blocked by preincubating cells with TS2/18 at 100 p~g/ml for 30 min 
and washing three times with HBS. Cells were incubated with bilayers at 
room temperature. LFA-3 site  densities on planar bilayers were deter- 
mined by radioimmunoassay, as previously described (9). 
Fluorescence Photobleaching Recovery 
Fluorescence photobleaching recovery (FPR) is used to measure the lat- 
eral mobility of fluorescently labeled proteins and lipids  in membranes 
(2). Spot FPR was performed on a Meridian Instruments (Okemos, Mich- 
igan) ACAS 570 Interactive Laser Cytometer. Data were analyzed using a 
nonlinear least squares method (5) to yield both the lateral diffusion coef- 
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to  diffuse on the time scale of the experiment (typically 45-90 s). The 
ACAS 570  uses a  computer-interfaced scanning stage to  generate line 
scans through the bleach site that are used to monitor non-bleached re- 
gions of the bilayer as an internal control. Bleaching pulses were 30-100 
ms in duration using a beam power of 200 p,W. Measuring pulses were 4 
Ixs in duration using a beam power of 100-225 p,W. The 1/e  2 diameter of 
the laser beam was measured as 1.3 +- 0.07 ixm (mean +- SD, n  =  6) using 
a 40×  1.3 N.A. oil immersion objective. Non-FITC fluorescence was ex- 
cluded from the emission detection system by using a 530 -+ 15 nm band 
pass filter. The fluorescence signal from unlabeled bilayers was less than 
10% of that from labeled bilayers, and was subtracted from the total signal. 
Image Analysis 
Two-dimensional fluorescence images of FITC-LFA-3 distribution in egg 
PC planar bilayers were obtained using the Meridian ACAS 570. Most im- 
ages were taken as 90 x  90-1xm fields using a step size of 0.5 Ixm. Bright 
field images of Jurkat cells on bilayers were used to draw outlines of the 
cells (i.e.,  cell profiles) on the fuorescence images. These outlines were 
used to determine projected cell areas and to define areas of the bilayer 
not in contact with ceils. Projected cell area was defined as the area of a 
disk in the horizontal plane through the widest part of the cell.  Contact 
sites were defined mathematically to include all pixels having fluorescence 
values/>120% of the average pixel intensity outside the cell outlines. The 
average autofluorescence of Jurkat cells adherent to unlabeled LFA-3 in 
egg PC planar bilayers was subtracted as a background. Average fluores- 
cence intensities within areas of cell contact  and non-cell contact were 
converted to LFA-3 surface densities by setting the average fluorescence 
intensity in multiple fields of FITC-LFA-3 equal to the surface density of 
LFA-3 measured by iodinated antibody binding. When laser power and 
photomultiplier tube gain were held constant, there was a linear relation- 
ship between fluorescence intensity (arbitrary units) and LFA-3 site den- 
sity determined by radioimmunoassay over the range used in these exper- 
iments (data not shown). 
Bound receptor densities were determined using conventions for equi- 
librium dialysis (43).  All data were corrected for background by subtrac- 
tion of fluorescence signals from planar bilayers without FITC-LFA-3 or 
from cells adherent to bilayers containing unlabeled LFA-3, as appropri- 
ate. The density of free LFA-3 in the bilayer (i.e., of LFA-3 not interacting 
with cells) was determined from the average LFA-3 density outside the 
cell outlines. The density of bound LFA-3 in a contact site was defined as 
the average LFA-3 density within the contact site minus the free LFA-3 
density in the bilayer. The total number of bound LFA-3 molecules was 
determined by integrating the density of bound LFA-3 over the contact 
area. 
Two-Dimensional Scatchard Analysis 
LFA-3 surface densities, determined as described above, were plotted as 
bound  on  the  abscissa  and  bound/free  on  the  ordinate.  Linear  least 
squares analysis was used to determine the slope, which is proportional to 
the negative reciprocal of the two-dimensional K d (mol/lxm2).  Extrapola- 
tion to the abscissa was used to determine the binding at saturation (mol/ 
izm  2 of contact area) (35). 
Results 
Redistribution  of LFA-3 into Areas of Planar Bilayers 
in Contact with Jurkat T Cells 
GPI-LFA-3 was purified from human erythrocytes by im- 
munoaffinity chromatography. FITC was  conjugated  to 
LFA-3 bound to a Sepharose-coupled antibody that blocks 
interaction  with  CD2,  to  protect  the  CD2-binding  site 
from modification by fluorophore. FITC-LFA-3 was in- 
corporated into phospholipid liposomes which were then 
Figure 1.  Pseudocolor fluo- 
rescence  images  of  FITC- 
LFA-3 distribution in glass- 
supported  planar  bilayers. 
(a)  Uniform  distribution 
of  FITC-LFA-3  (120  tool/ 
ixm  2) in a planar bilayer be- 
fore  interaction  with  cells. 
(b)  Distribution  of  FITC'- 
LFA-3  (initial  density, 
1,000 mol/ixm  ~)  in  a  planar 
bilayer 30 min after incuba- 
tion with Jurkat T  cells. (c) 
Distribution  of  FITC- 
LFA-3  (initial  density,  120 
mol/p,m  2)  in  a  planar  bi- 
layer  30  rain  after  incuba- 
tion with Jurkat T  cells. (d) 
Distribution  of  fluores- 
cence  in  a  planar  bilayer 
containing  120  mol/~m  2 of 
FITC-LFA-3  and 500 mol/ 
~m  2 of unlabeled LFA-1 30 
rain  after  incubation  with 
TS2/18 pretreated  Jurkat T 
cells. The projections of at- 
tached cells are outlined in 
white.  The  pseudocolor 
scale is marked in arbitrary 
fluorescence  units.  Each 
image represents 8,100 ~m  2. 
Dastin et al. Adhesion Receptor Affinity in a Contact Area  467 allowed  to interact  with  glass  coverslips to  form planar 
phospholipid  bilayers  on  the  glass  surface.  Quantitative 
fluorescence  imaging revealed  a  uniform distribution  of 
FITC-LFA-3 in the planar bilayers (Fig. 1 a). 
Upon incubation of planar bilayers with CD2 ÷ Jurkat T 
cells, FITC-LFA-3 redistributed into areas of contact with 
cells (Fig. 1, b and c, see also Figs. 4 and 5). The following 
experiment  demonstrated  that  FITC-LFA-3  redistribu- 
tion required specific interaction with CD2 on T cells. Jur- 
kat cells were allowed to adhere to planar bilayers formed 
by mixtures of liposomes containing FITC-LFA-3 and pu- 
rified LFA-1 in the presence of Mg  2÷. LFA-1 dependent 
adhesion, mediated by binding of LFA-1 to ICAMs on the 
Jurkat cells, had no effect on FITC-LFA-3 redistribution 
into the contact areas. Blocking of CD2 molecules on the 
Jurkat cells with TS2/18, a mAb known to block interaction 
of CD2  with  LFA-3,  prevented  redistribution  of FITC- 
LFA-3 into the LFA-l-mediated contact areas (Fig. 1 d). 
Kinetics of Contact Area Development 
Contact areas were defined operationally as areas of sig- 
nificantly increased LFA-3 accumulation. Fig. 2 shows the 
size  of contact  areas  and  the  average density  of bound 
LFA-3 within contact areas as a function of time after in- 
cubation of Jurkat cells with planar bilayers initially pre- 
senting 120 LFA-3 mol/p.m  2. The mean size of the contact 
areas increased rapidly over the first 28 min of incubation 
and then leveled off at an average size of 98  ~m  2. Like- 
wise, the density of bound LFA-3 in the contact areas in- 
creased steadily over the first 31 min before leveling off at 
an average density of 330 mol/p~m  2. Similar kinetics of con- 
tact area expansion were observed with bilayers initially 
presenting  120  (Fig.  2),  300,  and  1,000  LFA-3  mol//xm  2 
(not shown). 
Dependence of Bound LFA-3 Density on Cell Size 
Jurkat  cells  display  size  heterogeneity  in  log phase  cul- 
tures. The effect of this heterogeneity on FITC-LFA-3 ac- 
cumulation  was  assessed. FITC-LFA-3 fluorescence im- 
ages  were  analyzed  with  respect  to  projected  cell  area 
obtained  from  matched  bright-field  images.  Although 
larger cells formed larger contact areas within the planar 
bilayer, the average density of LFA-3 within these contact 
areas was the same as that in the contact areas formed by 
smaller cells (Fig. 3). 
The spatial distribution  of LFA-3 within contact areas 
was also analyzed. Most cells generated contact areas with 
a single, central area of concentrated ligand and decreas- 
ing ligand density toward the periphery (see Figs. 4 and 5). 
Peak fluorescence value within a contact area was defined 
as the greatest fluorescence value held by at least four ad- 
jacent pixels (i.e., by an area of at least 1 p~m2). The maxi- 
mum density of bound FITC-LFA-3 was 1,000 mol/ixm  2. 
Lateral Diffusion of LFA-3 in Contact Areas 
Fluorescence photobleaching recovery was used to mea- 
sure the fraction of FITC-LFA-3 that was free to diffuse 
in the planar bilayer (i.e., the fractional mobility) and the 
lateral diffusion coefficient of the mobile fraction (Figs. 4 
and 5; Table I). Fig. 4  shows the time course of fluores- 
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Figure 2.  Kinetics  of FITC-LFA-3 interaction  with  Jurkat  T 
ceils. Jurkat cells were allowed to adhere for various  lengths of 
time to planar egg PC bilayers containing FITC-LFA-3. Fluores- 
cence images were analyzed for (a) size of contact area (p~m  2) and 
(b) density  of bound FITC-LFA-3 in contact area (mol/g,  m2). 
Data were taken on planar bilayers initially presenting 120 LFA- 
3 mol/p~m  2. Each experimental point represents mean ___ SEM for 
all contact areas in a single microscope field. 
cence recovery following photobleaching of FITC-LFA-3 
in a contact area between a Jurkat T cell and a planar bi- 
layer initially presenting 120 LFA-3 mol/ixm  2. Fig. 5 shows 
prebleach, 0 s post-bleach and 90 s post-bleach line scans 
of FITC-LFA-3  fluorescence  in  contact  areas  between 
cells and bilayers initially presenting 120 (A, B), 300 (C, 
D) and 1,000  (E, F) LFA-3 mol/ixm  2. The pre-bleach line 
scans vividly display the relationship between initial LFA- 
3 density in the bilayer and peak LFA-3 accumulation in 
contact  areas.  FITC-LFA-3  in  planar  bilayers  reconsti- 
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Figure 3.  Cell size dependence of FITC-LFA-3 redistribution in 
planar bilayers initially presenting 1,000 LFA-3 mol/l~m  2. Jurkat 
cells were allowed to adhere to planar egg PC bilayers containing 
FITC-LFA-3. Fluorescence  images were analyzed for (a) size of 
contact area (ixm  z) and (b) density of bound FITC-LFA-3 in con- 
tact area (mol/~m  z) as a function of projected cell area obtained 
from matched bright field images. Each symbol represents data 
from a single adherent cell. 
tuted at 1,000  mol/l~m  2 had a lateral diffusion coefficient 
of 5.9  ~< 10 -9 cm2/s and a fractional mobility of 72% (Ta- 
ble I), in  agreement with our previous observations  (9). 
The diffusion coefficient of FITC-LFA-3 was decreased by 
50-75% in areas of contact with Jurkat cells (Table I). The 
fractional mobility remained high in contact areas, as indi- 
cated  by the  nearly  complete  recovery of FITC-LFA-3 
fluorescence after photobleaching of a contact area (Figs. 
4 and 5, Table I). 
Determination of Equilibrium Binding Parameters: 
Two-Dimensional Scatchard Analysis 
The density and total number of bound  and free FITC- 
LFA-3  molecules  in  contact  areas  between  Jurkat  cells 
and  planar  bilayers were  analyzed by methods  that  are 
routinely  applied  to  solution-phase  equilibrium  dialysis 
data. In the latter technique, receptors are restricted to a 
subregion  by  a  semipermeable  membrane,  and  small 
ligands  capable  of diffusion  through  the  membrane un- 
dergo net concentration on the side of the membrane that 
contains a specific receptor (43). The adhesion experiment 
here  was  modeled  as  a  two-dimensional  version  of the 
equilibrium dialysis experiment, in which CD2 and LFA-3 
molecules  were  spatially  restricted  by  the  Jurkat  cell 
plasma membrane and the planar bilayer, respectively. Ta- 
ble II summarizes the equilibrium surface density and to- 
tal number of free FITC-LFA-3 molecules in non-contact 
regions, and of bound FITC-LFA-3 molecules in regions 
of cell-bilayer contact, for three initial FITC-LFA-3 densi- 
ties. It should be noted that the three experimental FITC- 
LFA-3 surface densities span the physiological range in bio- 
logical membranes. Data from Table II were transformed 
into  a  plot of bound LFA-3/free LFA-3 on the ordinate 
and bound LFA-3 on the abscissa (35) (Fig. 6). The three 
points fell on a line with a negative reciprocal slope (Kd) of 
21 mol/~Lm  2 and an intercept on the abscissa (Bmax) of 430 
mol/~Lm  2. This analysis predicts that, since the density of 
CD2 on a T cell is on the order of 100 mol/~Lm  2, the CD2/ 
LFA-3 interaction in biological membranes will be driven 
toward saturation upon establishment of cell-cell contact. 
Discussion 
We have used glass-supported planar phospholipid bilay- 
ers reconstituted with defined surface densities of laterally 
mobile FITC-LFA-3 to quantify the interaction between 
CD2 and LFA-3 in a model cell-cell contact area. Analysis 
of LFA-3 surface distribution  and lateral mobility in the 
presence of CD2 ÷ Jurkat T  cells reveals time-dependent 
redistribution  of LFA-3 into contact sites and slowing of 
LFA-3 diffusion. Redistribution of LFA-3 reaches steady- 
state in 30 rain and is maintained for several hours. At low 
densities of GPI-LFA-3 in planar bilayers adhesion of Jur- 
kat cells increases dramatically between 5 and 20 min of 
incubation  (9), consistent with the time-course of LFA-3 
accumulation observed here. At higher GPI-LFA-3 densi- 
ties adhesion of Jurkat cells is stable at 5 rain (9), although 
redistribution of LFA-3 into contact areas does not reach 
steady-state until 30 rain of incubation, suggesting that for- 
mation of a sufficient number of CD2/LFA-3 complexes to 
stabilize  the  contacts  occurs  before  the  system  reaches 
equilibrium.  These  results  are  in  qualitative  agreement 
with those of McCloskey and Poo (26), who found that ad- 
hesion molecule (antibody-DNP complex) redistribution 
is closely associated with adhesion strengthening.  We ex- 
tend  the  results  of McCloskey and  Poo  (26)  on  a  high- 
affinity antibody/hapten interaction (solution-phase K  d  = 
10 -8  M)  to  an  interaction  between  adhesion  molecules 
with a much higher solution-phase Kd (1.6 ×  10 -5 M) (44). 
Our results indicate that CD2 in Jurkat cell membranes, 
like LFA-3 in the planar bilayers, also accumulates in con- 
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lateral  mobility  of  FITC- 
LFA-3 in a region of contact 
with  a  Jurkat  T  cell.  Jurkat 
cells  were  allowed  to  settle 
on a bilayer initially  present- 
ing  120 LFA-3 mol/l~m  2 for 
30 min  at  24°C. The  ACAS 
570 was used to monitor fluo- 
rescence  on  a  line  passing 
through the center of a cell. 
The  prebleach  scan  (green) 
shows FITC-LFA-3 accumu- 
lation  in  the  contact  area. 
The vertical line indicates the 
center of the bleaching spot, 
which was used  to initiate  a 
fluorescence  photobleaching 
recovery  experiment.  Fluo- 
rescence recovery was moni- 
tored by line scans at 0 (or- 
ange), 1.5, 3, 4.5, 6, 7.5 (red), 
9, 15, 21, 27, 33 (blue), 39, 45, 
51, 57, 63 (dark red),  69, 75, 
81, 87, and 93 (purple) seconds 
after  the  bleach.  Diffusion 
coefficient, 1.0 ×  10  -9 cm2/s. 
Fractional mobility, 85 %. 
tact areas. There are ~160,000 CD2 molecules on an aver- 
age Jurkat T cell (33), and ~43,000 are engaged in an aver- 
age  contact  area  at  steady-state.  CD2  molecules  are 
uniformly  distributed  on  Jurkat  cells  in  suspension  (un- 
published  observations),  yielding  an  initial  CD2  surface 
density between 100 and 200 mol/l~m  2. The maximum den- 
sity of bound  FITC-LFA-3 within  a  contact area,  which 
should  correspond  exactly to the  density  of bound  CD2 
within the contact site, is 1,000 mol/txm  2. Thus, CD2 redis- 
tributes by a maximum of 5-10-fold in contact areas. Con- 
sistent with this observation, T  cell CD2 is found to redis- 
tribute  into  areas  of  contact  with  cells  expressing  high 
levels of LFA-3 (30). 
FITC-LFA-3 in a  contact area manifests a reduced lat- 
eral  diffusion  coefficient compared  to FITC-LFA-3 out- 
side a contact area. Equilibrium binding of 83% of LFA-3 
molecules to CD2 within a  contact area causes the diffu- 
sion coefficient of LFA-3 to decrease from 5.9 ×  10  -9 cm2/ 
s  to  1.3  ×  10 -9  cm2/s.  One  explanation  for  this  finding 
could be that CD2/LFA-3 complexes have a  diffusion co- 
efficient  similar  to  that  of CD2  in  the  Jurkat  cell  mem- 
brane  (7.2  ×  10 -10 cm2/s)  (23). The suggestion that adhe- 
sion receptor/counter-receptor complexes diffuse laterally 
is intriguing, but may be difficult to establish in this system 
due to the rapid off-rate (>4 s -1) of the CD2/LFA-3 inter- 
action measured in solution (45). Nearly complete fluores- 
cence recovery is observed even when most of the  accu- 
mulated  FITC-LFA-3  in  a  contact  area  is  bleached, 
suggesting that bleached FITC-LFA-3 is replaced by fresh 
FITC-LFA-3 from  the  bilayer  outside  the  contact  area. 
This  result  suggests  that  transient  interactions  (19)  be- 
tween CD2 and LFA-3, even in the confines of the contact 
area, are a more likely explanation for the observed lateral 
diffusion  of LFA-3  than  the  coupled  diffusion  of long- 
lived CD2/LFA-3 complexes. 
The  binding  interaction  responsible  for the  accumula- 
tion of LFA-3 in contact areas was analyzed by methods 
used to analyze interactions  between  soluble  ligands  and 
receptors  (35).  We obtained  a  two-dimensional  Kd of 21 
mol/~m  z, although the lowest initial  LFA-3 density in bi- 
layers  was  120  mol/izm  2.  It was  not  possible  to  perform 
equilibrium experiments using planar bilayers initially pre- 
senting  fewer  than  120  mol/l~m  2,  because  such  experi- 
ments resulted in surface densities of free FITC-LFA-3 in 
non-contact regions that were below the fluorescence de- 
tection limits of the ACAS 570. Thus, it is not possible to 
conclude  from the  Scatchard  analysis  whether  the  CD2/ 
LFA-3 interaction exhibits one or more than one class of 
binding  sites.  The  region  of the  Scatchard  plot  sampled 
here spans the range of physiological LFA-3 surface densi- 
ties, however, and should be relevant to CD2/LFA-3 inter- 
actions in biological membranes. Furthermore,  the region 
of the Scatchard plot near the abscissa typically describes 
the  lowest  affinity  (highest  capacity)  sites.  Thus, if more 
than one class of sites is present, the experiments reported 
here should yield an upper limit for the two-dimensional 
Ks  of the  CD2/LFA-3 interaction.  Because  physiological 
surface densities of LFA-3 exceed our experimentally de- 
The Journal of Cell Biology, Volume •32,  1996  470 Figure 5.  Accumulation and lateral mobility of FITC-LFA-3 in regions of contact between Jurkat cells and planar bilayers containing 
different initial densities of FITC-LFA-3. Jurkat cells were allowed to settle on bilayers initially presenting 120 (A and B), 300 (C and 
D), or 1,000 (E and F) LFA-3 mol/ixm  2 for 30-120 min at 24°C. Prebleach (green), 0 s post-bleach (blue) and 90 s post-bleach (red) scans 
are shown to indicate the extents of FITC-LFA-3 accumulation, FITC-LFA-3 bleaching and FITC-LFA-3 fluorescence recovery, re- 
spectively. To minimize photobleaching during the fluorescence recovery phase of the experiment, the laser power and photomultiplier 
tube gain were adjusted for each bilayer to yield an acceptable signal level using minimal monitor beam power. Therefore, fluorescence 
intensity levels are not directly comparable among the various bilayer samples. 
termined lower limit for the half-saturation point (Ko) of 
CD2/LFA-3 binding, the physiological CD2/LFA-3 system 
appears to operate near saturation once a  contact area is 
formed. 
The  two-dimensional  Kd  measured  here  should  take 
into account all active and passive contributions of the Jur- 
kat  cells  to  the  CD2  affinity  for  LFA-3.  Adhesion  is 
thought to be regulated by a number of cellular processes, 
such as the association of adhesion receptors with the cy- 
toskeleton and receptor clustering. It is not clear whether 
these  active contributions modulate the  two-dimensional 
Kd,  however.  To  compare  the measured two- and three- 
dimensional KdS for the CD2/LFA-3 interaction, we make 
the conservative assumptions that  the  Ig-like domains of 
CD2  are conformationally fixed and  that  the  soluble re- 
combinant  molecules  used  by  van  der  Merwe  and  col- 
leagues to assess the three-dimensional Kd (45) are identi- 
cal  in  unitary  interaction  to  the  cell  surface  CD2  and 
Table I. Lateral Mobility of FITC-LFA-3 in Regions of Contact between Planar Bilayers and Jurkat T Cells 
Sample  Density*  f  D  B/Tot.  *  n 
FITC-LFA-3 in egg PC, no cells present  1,000 and 300  §  72 ±  15  II  5.9 ±  2.9  --  38 
FITC-LFA-3 in egg PC, Jurkat cells present  1,000  88 ±  10  2.8 ±  1.6  31%  42 
"  300  84 ±  14  2.3  ±  1.5  63%  31 
"  120  83 ±  13  1.3 ±  0.9  83%  63 
f, Fractional mobility, %. D, Diffusion coefficient, x 109 cmZls, n, Number of measurements. 
* Initial surface density, FITC-LFA-3 mol/Ixm e. 
Bound LFA-3 molecules/total LFA-3 molecules in contact site. 
Mobility data in the absence of cells were identical for bilayers containing LFA-3 at medium (300 lxm -2) and high ( 1,0130  ixm -2) surface densities. 
IIMean -+ SD. 
Dustin et al, Adhesion  Receptor Affinity  in o  Contact Area  471 Table II. Redistribution of FITC-LFA-3 into Regions of Contact between Planar Bilayers and Jurkat T Cells 
Equilibrium  surface  Equilibrium  surface  Equilibrium  number of 
Initial LFA-3  density of LFA-3  density of bound LFA-3  bound LFA-3 molecules 
surface density*  in non-contact  regions  N  in contact regions ~  (B + F)/F  ~  per cell ×  10 -~ll  n 
1,000  950 --  1491  4  430 --+ 94  1.4  4.3 ±  2.0  28 
300  250 ±  31  4  390 ±  183  2.6  3.9 +-- 2.5  26 
120  68 ±  15  5  330 ---  135  5.9  3.2 ±  1.7  49 
Data include all measurements performed on membranes incubated  with cells for at least  1 h (bilayers initially containing  LFA-3 at 120 mol/~m  2 and 1,000 mol//xm  2) or at least 
30 rain (bilayers initially containing  300 LFA-3 mol/txm2). N, number of planar bilayers, n, Number of cells. 
* FITC-LFA-3 mol/l~m  2. 
*  Bound LFA-3 mol/~m  2 in correct areas. 
Accumulation  of LFA-3 in contact areas defined as the total (bound plus free) density of LFA-3 in a contact area divided by the density of LFA-3 in areas of membrane not in 
contact with cells. 
IIBound LFA-3 molecules per cell, × 10  -4. 
1 Mean _+ SD. 
purified LFA-3 used  in  this  study.  We  also  assume that 
clustering  of CD2  on the T  cell  does not  alter the  two- 
dimensional Kd, although such clustering may alter adhe- 
sion properties (47). Our analysis therefore considers, as a 
first approximation, only geometric properties of the con- 
tact area. 
Bell and colleagues have suggested on theoretical grounds 
that the binding sites of adhesion  molecules in a  contact 
area  may be  limited  to  a  "confinement  region"  (3,  4). 
While this is an intriguing possibility, the concept has not 
been experimentally tested. The height of the confinement 
region (tr) can be calculated from the following relation- 
ship (4): 
O" (~m)  -~-  (gdx,y  (mol/ixm  2)  ×  10  I5  p~m3/dm  3)  +  (Kdx.y,z 
(mol/dm  3) ×  NA (mol/mol)) 
(D  == 
LL 
C 
0 
ro 
8 
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2- 
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Figure 6.  Scatchard  analysis of binding  between CD2 in Jurkat 
cell membranes and FITC-LFA-3 in planar bilayers. Data from 
Table II were transformed to bound LFA-3 and bound LFA-3/ 
free LFA-3 and plotted as described  in Materials  and Methods. 
Kd = 21 +-- 4 mol/ixm  2. Bma  x =  430 ± 10 mol/l~m  2. Errors were de- 
termined by using a linear regression  program (Regression,  ver- 
sion M1.23; Blackwell Scientific Publications, Oxford, UK). 
where Kdx,y is the two-dimensional Kd, gdx,y,z is the three- 
dimensional  Kd,  NA  is Avogadro's number  and  1  1 =  1 
dm  3. Using the two-dimensional Kd of 21 mol/p.m  2 and the 
three-dimensional Kd of 6  t~M (13)  (where both KdS are 
measured at room temperature), the calculated size of the 
confinement region for the CD2/LFA-3 interaction is 5.8 
nm. Our data provide strong support for the confinement 
region concept. If LFA-3 molecules were separated in the 
direction  normal to the membrane by the same average 
distance as in the plane of the membrane, then the average 
separation distance would be 220 nm rather than 5.8  nm. 
Thus,  confinement  generates  an  effective  increase  in 
three-dimensional  affinity of 220  nrn/5.8  nm, or 38-fold. 
Conversely, the average spacing of molecules at the three- 
dimensional Kd of 6 ~M predicts a two-dimensional Kd of 
230  mol/~xm 2.  The  effective increase  in  two-dimensional 
affinity due  to confinement is therefore 230  mol/t~m2/21 
mol/~m:,  or  ll-fold.  Note  that  the  38-fold  increase  in 
three-dimensional affinity is related to the 11-fold increase 
in two-dimensional affinity by the geometric relationship 
382/3  =  11. The decrease in two-dimensional Kd, generated 
by limitation of the CD2/LFA-3 interaction to a confine- 
ment region, appears to be important in maximizing bind- 
ing between  CD2 and LFA-3 at physiologic densities  on 
cell surfaces. Since cells with a high surface density of CD2 
and LFA-3 express on the order of 100 mol//xm  2 (9, 25, 33, 
37), and surface densities of LFA-3 can range considerably 
lower than this value (38), loss of the effect of confinement 
would result,  at equilibrium, in a  significant reduction  in 
bond formation and  a  consequent  reduction  in adhesion 
strength. 
Our observations may also provide a physical basis for 
the finding that CD2 and LFA-3 are often coexpressed on 
the same cell, yet do not appear to interact in cis, i.e., in 
the plane of the same membrane (17,37). The crystal struc- 
ture  of  CD2  suggests  that  bilayers  interacting  through 
CD2/LFA-3 bonds are separated by ~15 nm (20,46). The 
smaller size of the confinement region for the CD2/LFA-3 
interaction (i.e., 5.8 nm) could suggest that CD2 and LFA-3 
are topologically constrained so that the angle formed be- 
tween the long axis of either molecule and a line perpen- 
dicular  to the  bilayer is limited  to values that  allow the 
binding surfaces to remain in the confinement region.  If 
each molecule is constrained to a confinement region of 
(5.8 nm), the long axis of each molecule has length L (7.5 
nm for CD2), and the two molecules interact head-to-head 
through their NH2-terminal Ig-like domains, then the an- 
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tionship: 
O  =  COS -1 [(L- (~ +  2)) +  L]. 
For CD2 and LFA-3 the calculated angle of confinement 
is ~52  °. The mechanism by which the motion of CD2 or 
LFA-3 would be confined to the cone defined by this angle 
is unknown; it could, for example, involve interaction of 
the membrane proximal domain with the bilayer or of the 
entire molecule with the glycocalyx and neighboring gly- 
coproteins. Of note, the stalk region of six amino acid resi- 
dues that joins the COOH-terminus of IgSF domain 2 to 
the  transmembrane  segment  is  highly conserved among 
CD2 molecules in different species, suggesting that this re- 
gion has an important function (42). The crystal structure 
of CD2 suggests that a confinement angle >65  ° would be 
required for cis interactions to occur (20). Thus, our find- 
ings may provide a  physical explanation consistent with 
the observation that cis, non-adhesion promoting, interac- 
tions do not compete with trans, adhesion promoting, in- 
teractions. Further, CD2 and LFA-3 are homologous (36), 
are closely linked genetically (50), interact through homol- 
ogous binding surfaces (46), and  are postulated to have 
evolved from a common ancestor that interacted as a ho- 
modimer through cis interactions (49). Prevention of cis 
interactions of the common ancestor by topological con- 
straints,  as  manifested  in  the  confinement  angle,  could 
have been critical in permitting the evolution of adhesive 
trans interactions, in analogy to the CD2:CD2 interaction 
seen in the CD2 crystal structure (20). We note that the 
calculated confinement distance  of 5.8  nm  and  the  pre- 
dicted membrane separation of 15 nm differ by only 2.6- 
fold. If either the two-dimension Kd measured here or the 
three-dimensional Kd measured by Davis et al. (13) is in 
error by this amount, then the argument for a confinement 
angle would disappear. 
The notion of a confinement region for adhesion recep- 
tors has implications for adhesive interactions mediated by 
receptors of similar or dissimilar size. The CD2/LFA-3 in- 
teraction occurs naturally along side other adhesion recep- 
tor interactions, including those involving LFA-1/ICAM-1 
and antigen receptors such as the T  cell receptor (TCR) 
and  CD16  (a low-affinity IgG Fc receptor). It has been 
pointed out (40, 46) that the molecular dimensions of CD2 
and LFA-3 (20, 46) are similar to those predicted for the 
TCR (12) and MHC proteins (6, 8), suggesting that CD2 
and LFA-3 may be effective in establishing a contact envi- 
ronment in which the TCR can function optimally. In con- 
trast, LFA-1 and ICAM-1 appear capable of mediating ad- 
hesion with a larger intercellular distance than that preferred 
by  the  CD2/LFA-3  or  TCR/MHC  protein  interaction. 
Contact  areas  involving  LFA-1  and  ICAM-1  could  be 
physically segregated (i.e., laterally separated) from areas 
containing CD2/LFA-3 and TCR/MHC proteins, allowing 
each system to maintain  an  optimal cell-cell separation 
distance and confinement region. Adhesion receptors with 
strikingly different geometries have been described: adhe- 
sion may be regulated in some systems by changes in inter- 
cellular distance (44). 
We have described a novel approach to the molecular 
analysis  of  adhesion  molecule  interactions  in  a  contact 
area.  The results allow calculation of a  two-dimensional 
Kd  that  relates directly to the  natural  function of these 
molecules in adhesion.  Our findings  demonstrate that  a 
three-dimensional K d must be interpreted in the context of 
additional topological constraints on adhesion molecules 
in a membrane environment to determine the relationship 
between two-dimensional and  three-dimensional KdS. In 
fact, both  the  two-  and  three-dimensional KdS must  be 
known  to  characterize fully the  interaction of adhesion 
molecules. 
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